If proven safe, GLP-1 receptor agonists could provide an effective alternative for GDM management, enhancing both maternal and fetal health outcomes
The present investigation has been supported partly by funds from the American Diabetes Association and the National Institutes of Health (1-17-IBS-258 and R21DK113446-01 to MDiF)
In these roles, NAC may be a useful monotherapy or augmentation strategy for psychiatric disorders related to oxidative stress (e.g., schizophrenia and bipolar disorder) and/or psychiatric syndromes characterized by impulsive/compulsive symptoms (e.g., trichotillomania, nail biting, pathological hair pulling, substance misuse, and gambling)
Lilly brought in $12.7 billion in revenue for the first quarter, up 44% from $8.8 billion Q1 2024
doi: 10.1016/j.expneurol.2004.08.022 175 ZhangD